Cognitive function in breast cancer patients prior to adjuvant treatment

Breast Cancer Research and Treatment

Volumn 110, Issue 1, 2008, Pages 143-152

  Ahles, Tim A ^a,b   Saykin, Andrew J ^a,c   McDonald, Brenna C ^a,c   Furstenberg, Charlotte T ^a   Cole, Bernard F ^a   Hanscom, Brett S ^a   Mulrooney, Tamsin J ^a   Schwartz, Gary N ^a   Kaufman, Peter A ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Cognitive function; Neuropsychological testing; Psychological function

Indexed keywords

ADJUVANT THERAPY; ADULT; ARTICLE; BLOOD CELL COUNT; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; COGNITION; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; NUTRITIONAL STATUS; PRIORITY JOURNAL; PSYCHOLOGIC TEST; THROMBOCYTE COUNT; THYROID FUNCTION;

ADULT; ANXIETY; BREAST NEOPLASMS; COGNITION; DEPRESSION; DNA DAMAGE; FEMALE; HUMANS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 44849099262     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-007-9686-5     Document Type: Article

References (49)

1. Wieneke MH, Dienst ER (1995) Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psychooncology 4:61-66
2. van Dam FS, Schagen SB, Muller MJ et al (1998) Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst 90:210-218
3. Schagen SB, van Dam FS, Muller MJ et al (1999) Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 85:640-650
4. Brezden CB, Phillips KA, Abdolell M et al (2000) Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 18:2695-2701
5. Tchen M, Juffs HG, Downie FP et al (2003) Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol 21:4175-4183
6. Castellon SA, Ganz PA, Bower JE et al (2004) Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol 26:955-969
7. Ahles TA, Saykin AJ, Furstenberg CT et al (2002) Neuropsychological impact of standard-dose chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 20:485-493
8. Tannock IF, Ahles TA, Ganz PA, van Dam FS (2004) Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J Clin Oncol 22:2233-2239
9. Wefel JS, Lenzi R, Theriault RL et al (2004) The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer 100:2292-2299
10. Schilling V, Jenkins V, Morris R et al (2005) The effects of adjuvant chemotherapy on cognition in women with breast cancer-preliminary results of an observational study. Breast 14:142-150
11. Mar Fan HG, Houede-Tchen N, Yi QL et al (2005) Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. J Clin Oncol 23:8025-8032
12. Jenkins V, Shilling V, Deutsch G et al (2006) A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer 94:828-834
13. Wefel JS, Lenzi R, Theriault R et al (2004) Chemobrain in breast carcinoma? A prologue. Cancer 101:466-475
14. Cimprich B, So H, Ronis DL et al (2005) Pre-treatment factors related to cognitive functioning in women newly diagnosed with breast cancer. Psychooncology 14:70-78
15. Ahles TA, Saykin AJ (2002) Breast cancer chemotherapy-related cognitive dysfunction. Clin Breast Cancer 3(Suppl 3):S84-S90
16. Rasmussen LS, Johnson T, Kuipers HM et al (2003) Does anaesthesia cause postoperative cognitive dysfunction? A randomized study of regional versus general anaesthesia in 438 elderly adults. Acta Anaesthesiol Scand 47:260-266
17. Johnson T, Monk T, Rasmussen LS et al (2002) Postoperative cognitive dysfunction in middle-aged patients. Anesthesiology 96:1351-1357
18. Wagner LI, Butt Z, Sabatino T (2005) Prechemotherapy cognitive function in patients with cancer. ASCO Education Book, pp 392-397
19. Moretti R, Torre P, Antonello RM et al (2004) Vitamin B12 and folate depletion in cognition: a review. Neurol India 52:310-318
20. Shilling V, Jenkins V, Trapala IS (2006) The (mis)classification of chemo-fog-methodological inconsistencies in the investigation of cognitive impairment after chemotherapy. Breast Cancer Res Treat 95:125-129
21. Wilkinson GS (1993) WRAT3 Administration Manual. Wide Range, Inc., Wilmington, DE
22. The Psychological Corporation (1999) Wechsler abbreviated scale of intelligence. The Psychological Corporation, San Antonio, TX
23. Delis DC, Kaplan E, Kramer JH (2001) Delis-kaplan executive function system. The Psychological Corporation, San Antonio, TX
24. Delis DC, Kramer JH, Kaplan E, Ober BA (2000) California verbal learning test. 2nd edn. Adult Version Manual. The Psychological Corporation, San Antonio, TX
25. The Psychological Corporation (1997) WAIS-III wechsler adult intelligence scale, IIIrd edn. WMS-III Wechsler Memory Scale, IIIrd edn Updated Technical Manual. The Psychological Corporation, San Antonio, TX
26. Fischer JS, Jak AJ, Kniker JE et al (2001) Multiple Sclerosis Functional Composite (MSFC) Administration and scoring manual. National Multiple Sclerosis Society, New York
27. Lafayette Instrument (1989) Grooved pegboard: instruction/owner's manual. Lafayette Instrument, Lafayette, IN
28. Gordon M, McClure FD, Aylward GP (1986) The gordon diagnostic system instruction manual and interpretive guide. Gordon Systems Inc., Dewitt, NY
29. Radloff LS (1977) The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385-392
30. Plutchick R, Conte HR (1989) Self-report scales for the measurement of depression. Psychiatr Ann 19:367-371
31. Spielberger CD, Gorsuch RL, Lushene RG (1983) Manual for the state-trait anxiety inventory for adults. Mind Garden, Palo Alto, CA
32. Hann DM, Jacobsen PB, Martin SC et al (1997) Fatigue in women treated with bone marrow transplantation for breast cancer: a comparison with women with no history of cancer. Support Care Cancer 5:44-52
33. Seidenberg M, Haltiner A, Taylor MA et al (1994) Development and validation of a multiple ability self-report questionnaire. J Clin Exp Neuropsychol 16:93-104
34. Graybill FA (1976) Theory and application of the linear model. Duxbury, Boston, pp 231-236
35. Turk DC, Okifuji A (1994) Detecting depression in chronic pain patients: adequacy of self-reports. Behav Res Ther 32:9-16
36. Altaha R, Abraham J (2003) Paraneoplastic neurologic syndrome associated with occult breast cancer: a case report and review of the literature. Breast J 9:417-419
37. Georgian-Smith D, Ellis GK, Kraft GH (2003) Amphiphysin paraneoplastic syndrome: a delayed diagnosis of breast carcinoma. Breast J 9:316-318
38. Heflin LH, Meyerowitz BE, Hall P et al (2005) Cancer as a risk factor for cognitive deficits and dementia. J Natl Cancer Inst 97:854-856
39. Wefel JS, Meyers CA (2005) Cancer as a risk factor for dementia: a house built on shifting sand. J Natl Cancer Inst 97:788-789
40. Ahles TA, Saykin AJ (2007) Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 7:192-201
41. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to virchow? Lancet 357:539-545
42. de Visser KE, Eichten A, Coussens LM (2006) Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 6:24-37
43. Wilson CJ, Finch CE, Cohen HJ (2002) Cytokines and cognition: the case for a head-to-toe inflammatory paradigm. JAGS 50:2041-2056
44. Maier SF, Watkins LR (2003) Immune-to-central nervous system communication and its role in modulating pain and cognition: implications for cancer and cancer treatment. Brain Behav Imm 17:S125-S131
45. Cleeland CS, Bennett GJ, Dantzer R et al (2003) Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer 97:2919-2925
46. Goode EL, Ulrich CM, Potter JD (2002) Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11:1513-1530
47. Blasiak J, Arabski M, Krupa R et al (2004) Basal oxidative and alkylative DNA damage, DNA repair efficacy, and mutagen sensitivity in breast cancer. Mutat Res 554:139-148
48. Migliore L, Fontana I, Trippi F et al (2005) Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients. Neurobiol Aging 26:567-573
49. Rolig RL, McKinnon PJ (2000) Linking DNA damage and neurodegeneration. Trends Neurosci 23:417-424